Cerapedics Announces FDA Breakthrough Device Designation Granted for P-15L Bone Graft for the Treatment of Degenerative Disc Disease
P-15L Bone Graft is currently being studied in the Company’s ASPIRE IDE clinical trial WESTMINSTER, CO - April 29, 2021 - Cerapedics Inc., an ortho-biologics company dedicated to enhancing the science of bone repair, today...